(Q53135612)

11 May 2018

title

Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. (English)

1 reference

11 May 2018

idiopathic pulmonary fibrosis

1 reference

1 reference

1 reference

7

1 reference

11 May 2018

Ulrich Costabel

3

object named as

Ulrich Costabel

1 reference

11 May 2018

Vincent Cottin

4

object named as

Vincent Cottin

1 reference

11 May 2018

author name string

Ganesh Raghu

1

1 reference

11 May 2018

Kevin K Brown

2

1 reference

11 May 2018

Roland M du Bois

5

1 reference

11 May 2018

Joseph A Lasky

6

1 reference

11 May 2018

James P Utz

8

1 reference

11 May 2018

Rezaul K Khandker

9

1 reference

11 May 2018

Lawrence McDermott

10

1 reference

11 May 2018

Saeed Fatenejad

11

1 reference

11 May 2018

language of work or name

English

0 references

publication date

31 July 2008

1 reference

11 May 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

11 May 2018

volume

178

1 reference

11 May 2018

issue

9

1 reference

11 May 2018

page(s)

948-955

1 reference

11 May 2018

Idiopathic Pulmonary Fibrosis

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

Incidence and prevalence of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

Nonspecific interstitial pneumonia versus usual interstitial pneumonia: differences in the density histogram of high-resolution CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

Antioxidant therapy for idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis. Possible role of transforming growth factor beta and tumor necrosis factor alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

A randomized trial of etanercept as monotherapy for psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

Use of sedatives and neuromuscular blockers in a cohort of patients receiving mechanical ventilation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

A sharper Bonferroni procedure for multiple tests of significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

High-dose acetylcysteine in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

The clinical course of patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

Acute exacerbations of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200709-1446OC

10.1164/RCCM.200709-1446OC

21 January 2018

Identifiers

DOI

1 reference

11 May 2018

PubMed ID

18669816

1 reference

11 May 2018